View Future GrowthNextel Medical 過去の業績過去 基準チェック /06Nextel Medicalの収益は年平均-656%で減少しているが、Biotechs業界はgrowingで34.1%年平均の収益となった。主要情報-656.00%収益成長率4.64%EPS成長率Biotechs 業界の成長17.04%収益成長率n/a株主資本利益率n/aネット・マージン5,154.75%前回の決算情報31 Mar 2025最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • May 12NexTel Medical Corp Enters Final Stage for Commercial LaunchNexTel Medical Corp. announced the commencement of the final stability phase for its inaugural line of commercial exosome products. Last week, NexTel successfully initiated the stability testing phase, a critical precursor to market entry. Under the supervision of Lab Director and Dr. Hausman, a production batch underwent rigorous filtration and diagnostic screening. Utilizing advanced PCR technology, samples were tested for common contaminants, using a threshold of (“0”), including: Shiga-like toxin-producing E. coli, Salmonella, Pseudomonas aeruginosa, Staphylococcus aureus. The samples tested negative for all four organisms. Currently, stability vials are being monitored at both room temperature and refrigeration. Success at the 30-day mark will allow NexTel to proceed with an immediate commercial launch, establishing a definitive shelf life for additive-free, pure exosome products.お知らせ • Mar 17Exousia Pro, Inc. Announces Favorable Litigation Settlement Highlighting Significant Debt Elimination And Share Cancellation To Enhance Shareholder ValueExousia Pro, Inc. had announced the successful settlement of its outstanding litigation involving a former Director. This landmark agreement represents a pivotal financial milestone for the Company, delivering immediate and substantial value to current shareholders by improving the capital structure and strengthening the balance sheet. Under the terms of the settlement, which is expected to close within 30 days, Exousia Pro will make a one-time, strategic payment of $147,500 to the involved parties. In exchange, the Company will secure highly favorable financial restructuring outcomes. For the purposes of the Company’s upcoming financial reporting and audits, these events will be recorded under Generally Accepted Accounting Principles (GAAP) and will provide the following distinct benefits to the Company and its shareholders: Significant Debt Reduction: The settlement triggers the complete cancellation of a $200,000 promissory note issued at closing, as well as the cancellation of the remaining balance on the note tied to the control block of Preferred Stock. Removing these liabilities immediately strengthens Exousia's balance sheet and frees up future cash flow. Reversal of Share Dilution: The agreement secures the cancellation and return to treasury of 6,297,511 shares of Common Stock. Retiring this sizable block of shares reverses prior dilution, directly increasing the equity value, earnings-per-share potential, and ownership percentage of all current shareholders. Enhanced Audit Readiness and Transparency: By formally clearing these contested liabilities and equity issuances from the general ledger under GAAP, the Company is positioned for a clean, streamlined audit. This provides greater financial transparency and reinforces confidence within the investment community. By resolving this legacy dispute efficiently, Exousia Pro’s management team can now focus entirely on advancing its core clinical pipeline and expanding its telehealth initiatives without the distraction or financial overhang of litigation.お知らせ • Nov 18LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million.LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million on November 11, 2025. For consideration, 62.22 million shares of LAMY common stock will be given to the shareholders of Exousia Ai. The trannsaction was subject to approval from LAMY board and the same was approved. LAMY (OTCPK:LMMY) completed the acquisition of Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) on November 17, 2025.お知らせ • Jan 07Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG).Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025. As part of consideration, cash and stock of 47 million restricted shares of its Common stock is paid to Ludwig Enterprises. Marijuana Inc. further agreed to assume liabilities under $0.075 million and issued Ludwig a Note for $0.1 million. Marijuana Inc. (OTCPK:MAJI) completed the acquisition of Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025.お知らせ • May 24GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc.GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc. on May 23, 2023. As a result of the merger, existing equity holders of Marijuana Inc. have exchanged their shares for equity in the consolidated public company. The combined entity is poised to capitalize on the synergies between the two organizations, fostering operational efficiencies and unlocking new avenues for value creation. GRN Holding Corporation (OTCPK:GRNF) completed the acquisition of Marijuana, Inc. on May 23, 2023.お知らせ • Aug 06+ 1 more updateGRN Holdings Corporation, Inc. Appoints Donald Steinberg as DirectorGRN Holdings Corporation Inc. announced the appointment of Donald Steinberg as Director, the Company’s former CEO, has resigned from the Company’s board of directors, leaving Donald Steinberg as the Company’s sole director. Don has decades of involvement in the Marijuana Industry, going back to the 70’s when he was noted as the largest importer of Marijuana into the U.S. While in Marijuana “college” he studied stock options and wrote option volatility programs that he implemented on all of the option exchanges in the U.S. After that and seeing the large use of phone cards in Europe, he founded GlobalCom2000 which became a premier phone card company in the U.S. namely with the 7-11 card, the 1st card in the U.S. with a corporate logo and distribution in hundreds of 7-11 stores. He then went on to create One World Communications, which became the largest telecom affiliate marketing company in the world with 187 offices and training centers in over 30 countries and 200,000 affiliates. After One World Communications, he created Club Vivanet to provide financial services. In 2009, he formed Medical Marijuana Inc., which was the 1st company to be on a U.S. stock market. After building the market cap of Medical Marijuana Inc. to a market cap of nearly $100 million, he retired to Florida. In 2015, he formed Marijuana Company of America and resigned in 2019. In that year, he formed Marijuana Strategic Ventures to assist companies in the “going public process”. He recently changed the name of that company to Mushrooms Inc. to participate in the Mushrooms industry.収支内訳Nextel Medical の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:MAJI 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費31 Mar 250-10031 Dec 24000031 Dec 23000031 Jan 210-11031 Oct 200-11031 Jul 200-11030 Apr 20000031 Jan 20000031 Oct 19000031 Jul 19000030 Apr 19000031 Jan 19000031 Oct 18000031 Jul 18000030 Apr 180000質の高い収益: MAJIは現在利益が出ていません。利益率の向上: MAJIは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: MAJIの過去 5 年間の前年比収益成長率がプラスであったかどうかを判断するにはデータが不十分です。成長の加速: MAJIの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: MAJIは利益が出ていないため、過去 1 年間の収益成長をBiotechs業界 ( 72.8% ) と比較することは困難です。株主資本利益率高いROE: MAJIの負債は資産を上回っているため、自己資本利益率を計算することは困難です。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/31 13:54終値2026/07/31 00:00収益2025/03/31年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Nextel Medical Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 12NexTel Medical Corp Enters Final Stage for Commercial LaunchNexTel Medical Corp. announced the commencement of the final stability phase for its inaugural line of commercial exosome products. Last week, NexTel successfully initiated the stability testing phase, a critical precursor to market entry. Under the supervision of Lab Director and Dr. Hausman, a production batch underwent rigorous filtration and diagnostic screening. Utilizing advanced PCR technology, samples were tested for common contaminants, using a threshold of (“0”), including: Shiga-like toxin-producing E. coli, Salmonella, Pseudomonas aeruginosa, Staphylococcus aureus. The samples tested negative for all four organisms. Currently, stability vials are being monitored at both room temperature and refrigeration. Success at the 30-day mark will allow NexTel to proceed with an immediate commercial launch, establishing a definitive shelf life for additive-free, pure exosome products.
お知らせ • Mar 17Exousia Pro, Inc. Announces Favorable Litigation Settlement Highlighting Significant Debt Elimination And Share Cancellation To Enhance Shareholder ValueExousia Pro, Inc. had announced the successful settlement of its outstanding litigation involving a former Director. This landmark agreement represents a pivotal financial milestone for the Company, delivering immediate and substantial value to current shareholders by improving the capital structure and strengthening the balance sheet. Under the terms of the settlement, which is expected to close within 30 days, Exousia Pro will make a one-time, strategic payment of $147,500 to the involved parties. In exchange, the Company will secure highly favorable financial restructuring outcomes. For the purposes of the Company’s upcoming financial reporting and audits, these events will be recorded under Generally Accepted Accounting Principles (GAAP) and will provide the following distinct benefits to the Company and its shareholders: Significant Debt Reduction: The settlement triggers the complete cancellation of a $200,000 promissory note issued at closing, as well as the cancellation of the remaining balance on the note tied to the control block of Preferred Stock. Removing these liabilities immediately strengthens Exousia's balance sheet and frees up future cash flow. Reversal of Share Dilution: The agreement secures the cancellation and return to treasury of 6,297,511 shares of Common Stock. Retiring this sizable block of shares reverses prior dilution, directly increasing the equity value, earnings-per-share potential, and ownership percentage of all current shareholders. Enhanced Audit Readiness and Transparency: By formally clearing these contested liabilities and equity issuances from the general ledger under GAAP, the Company is positioned for a clean, streamlined audit. This provides greater financial transparency and reinforces confidence within the investment community. By resolving this legacy dispute efficiently, Exousia Pro’s management team can now focus entirely on advancing its core clinical pipeline and expanding its telehealth initiatives without the distraction or financial overhang of litigation.
お知らせ • Nov 18LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million.LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million on November 11, 2025. For consideration, 62.22 million shares of LAMY common stock will be given to the shareholders of Exousia Ai. The trannsaction was subject to approval from LAMY board and the same was approved. LAMY (OTCPK:LMMY) completed the acquisition of Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) on November 17, 2025.
お知らせ • Jan 07Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG).Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025. As part of consideration, cash and stock of 47 million restricted shares of its Common stock is paid to Ludwig Enterprises. Marijuana Inc. further agreed to assume liabilities under $0.075 million and issued Ludwig a Note for $0.1 million. Marijuana Inc. (OTCPK:MAJI) completed the acquisition of Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025.
お知らせ • May 24GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc.GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc. on May 23, 2023. As a result of the merger, existing equity holders of Marijuana Inc. have exchanged their shares for equity in the consolidated public company. The combined entity is poised to capitalize on the synergies between the two organizations, fostering operational efficiencies and unlocking new avenues for value creation. GRN Holding Corporation (OTCPK:GRNF) completed the acquisition of Marijuana, Inc. on May 23, 2023.
お知らせ • Aug 06+ 1 more updateGRN Holdings Corporation, Inc. Appoints Donald Steinberg as DirectorGRN Holdings Corporation Inc. announced the appointment of Donald Steinberg as Director, the Company’s former CEO, has resigned from the Company’s board of directors, leaving Donald Steinberg as the Company’s sole director. Don has decades of involvement in the Marijuana Industry, going back to the 70’s when he was noted as the largest importer of Marijuana into the U.S. While in Marijuana “college” he studied stock options and wrote option volatility programs that he implemented on all of the option exchanges in the U.S. After that and seeing the large use of phone cards in Europe, he founded GlobalCom2000 which became a premier phone card company in the U.S. namely with the 7-11 card, the 1st card in the U.S. with a corporate logo and distribution in hundreds of 7-11 stores. He then went on to create One World Communications, which became the largest telecom affiliate marketing company in the world with 187 offices and training centers in over 30 countries and 200,000 affiliates. After One World Communications, he created Club Vivanet to provide financial services. In 2009, he formed Medical Marijuana Inc., which was the 1st company to be on a U.S. stock market. After building the market cap of Medical Marijuana Inc. to a market cap of nearly $100 million, he retired to Florida. In 2015, he formed Marijuana Company of America and resigned in 2019. In that year, he formed Marijuana Strategic Ventures to assist companies in the “going public process”. He recently changed the name of that company to Mushrooms Inc. to participate in the Mushrooms industry.